BR0007186A - Processo para produzir uma "forma livre", biologicamente ativa, purificada, de gama interferon humano (hig) recombinante - Google Patents

Processo para produzir uma "forma livre", biologicamente ativa, purificada, de gama interferon humano (hig) recombinante

Info

Publication number
BR0007186A
BR0007186A BR0007186-2A BR0007186A BR0007186A BR 0007186 A BR0007186 A BR 0007186A BR 0007186 A BR0007186 A BR 0007186A BR 0007186 A BR0007186 A BR 0007186A
Authority
BR
Brazil
Prior art keywords
biologically active
recombinant human
hig
purified
produce
Prior art date
Application number
BR0007186-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Sharad Kumar Vyas
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of BR0007186A publication Critical patent/BR0007186A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR0007186-2A 2000-02-01 2000-03-20 Processo para produzir uma "forma livre", biologicamente ativa, purificada, de gama interferon humano (hig) recombinante BR0007186A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN49CA2000 IN187900B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2000-02-01 2000-02-01
PCT/IB2000/000318 WO2001057218A1 (en) 2000-02-01 2000-03-20 A process for producing purified biologically active, free form of recombinant human interferon gamma

Publications (1)

Publication Number Publication Date
BR0007186A true BR0007186A (pt) 2002-04-23

Family

ID=11096979

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007186-2A BR0007186A (pt) 2000-02-01 2000-03-20 Processo para produzir uma "forma livre", biologicamente ativa, purificada, de gama interferon humano (hig) recombinante

Country Status (5)

Country Link
EP (1) EP1171603A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU3185400A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR0007186A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN187900B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2001057218A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102925519B (zh) * 2012-11-14 2014-04-16 广东药学院 一种重组肝靶向干扰素的制备工艺
CN102994596A (zh) * 2012-12-11 2013-03-27 河南省康星药业股份有限公司 乳糖代替IPTG诱导重组鸡α干扰素在大肠杆菌中的表达

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79124B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1982-12-22 1984-10-02 Genentech Inc
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4966844A (en) * 1985-09-03 1990-10-30 Amgen Method for microbial cell killing
DE19604583C2 (de) * 1996-02-08 1999-11-18 Fraunhofer Ges Forschung Verfahren zur Synthese von löslichen, rekombinanten Proteinen aus Bakterienzellen

Also Published As

Publication number Publication date
EP1171603A1 (en) 2002-01-16
WO2001057218A1 (en) 2001-08-09
IN187900B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2002-07-20
AU3185400A (en) 2001-08-14

Similar Documents

Publication Publication Date Title
BR0015533A (pt) Iduronidase-alfa-l recombinante, métodos para sua produção e purificação e métodos para tratamento de doenças causadas por deficiências da mesma
BR9106702A (pt) Analogo de oligonucleotideos e processos para modular a producao de uma proteina por um organismo e para tratar um organismo
BR0015508A (pt) Gelatinas recombinantes, suas composições e processo de produção e emprego das mesmas
BR0012450A (pt) Benzimidazóis substituìdos
AR024558A1 (es) Composiciones del peptido a-beta y procesos para producir las mismas
NO963239L (no) Klorpyrimid-mellomprodukter
DK0409472T3 (da) Knoglemorfogenetisk protein
SI1501507T1 (sl) Tetrahidropiranil ciklopentil tetrahidropiridopiridin modulatorji s kemokinsko receptorsko aktivnostjo
ECSP066355A (es) Compuestos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de la colecistocinina 2
BR0110492A (pt) Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto
ES2165878T3 (es) Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.
ATE295829T1 (de) Verwendung von biologisch aktivem glas zum schneiden von biologisch aktivem glas
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
CY1109648T1 (el) Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αγωγη εγκεφαλικου επεισοδιου
MA28613B1 (fr) Macrocycles d'amide antibacteriens
BR0007186A (pt) Processo para produzir uma "forma livre", biologicamente ativa, purificada, de gama interferon humano (hig) recombinante
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
WO2004043373A3 (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
BR0001342A (pt) Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes
DE50114181D1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz
BR0311385B1 (pt) oxatinacarboxamidas, seu processo de preparação e seu emprego, agente e seu processo de preparação, bem como processo para o combate de microorganismos indesejados
ATE368740T1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
AU2002251788A1 (en) Novel compounds and uses thereof
SE9701409D0 (sv) Treatment of rheumatoid arthritis
BR0211941A (pt) Processo para produzir 2-ceto-l-gulonato de sódio por fermentação e recuperar cristais de monoidrato de ácido 2-ceto-l-gulÈnico, cultura mista de gluconobacter oxydans, gluconobacter oxydans, bacillus thuringiensis, e, uso de microorganismo.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A, 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.